Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lesions

Care should be taken in handling and using iodine, as contact with the skin can cause lesions iodine vapor is intensely irritating to the eyes and mucus membranes. The maximum allowable concentration of iodine in air should not exceed 1 mg/nu (8-hour time-weighted average -40-hour). [Pg.123]

A II H 11 Its 2HC1 salt (Agr307) opposes the formation of extensive infarct lesions 910... [Pg.148]

Pneumogstis carini pneumonia (PCP), the most common of the opportunistic infections, occurs in more than 80% of AIDS patients (13). Toxoplasmosis, a proto2oan infection of the central nervous system, is activated in AIDS patients when the 004 count drops and severe impairment of ceU-mediated immunity occurs. Typically, patients have a mass lesion(s) in the brain. These mass lesions usually respond well to therapy and can disappear completely. Fungal infections, such as CTyptococcalmeningitis, are extremely common in AIDS patients, and Histop/asma capsulatum appears when ceU-mediated immunity has been destroyed by the HIV vims, leading to widespread infection of the lungs, Hver, spleen, lymph nodes, and bone marrow. AIDS patients are particularly susceptible to bacteremia caused by nontyphoidal strains of Salmonella. Bacteremia may be cleared by using antibiotic therapy. [Pg.33]

Mode of Action. The fundamental biochemical lesion produced by arsenicals is the result of reaction between As " and the sulfhydryl groups of key respiratory enzymes such as pymvate and a-ketoglutarate dehydrogenases. [Pg.268]

Mode of Motion. The cyclodienes, like lindane and toxaphene, affect the nerve axon produciag hyperactivity, convulsions, prostration, and death. The biochemical lesion is the competitive inhibition of the y-aminobutyric acid (GABA) neurotransmitter binding site of the nerve axon. Spray workers with lengthy exposure to dieldrin have suffered from prolonged and repeated central nervous system disturbances produciag epileptiform coavulsioas. Similar disturbances occurred ia workers heavily exposed to chlordecoae. [Pg.278]

There are certain weU-estabUshed facts about olfaction (6). AU normal people can smell. People suffering from brain lesions, injured olfactory nerve, or obstmcted nasal passages may be anosmic. Cases of preferential anosmia, ie, abUity to sense certain smells and not others, are not weU estabUshed. Such cases occur, but Utde is known of them. [Pg.292]

The demonstration that injected or force-fed neonatal rodents given extremely high doses of MSG showed evidence of brain lesions, has led to much additional research to determine any possible link between neurotoxicity and human use of MSG (33). However, no evidence from animal tests indicates that MSG in the diet causes brain damage in humans (34). [Pg.305]

Laser ablation systems hold considerable promise if restenosis (reblocking of the arteries) rates are reduced. The rate as of 1995 is 30%, typically within six months. Mechanical or atherectomy devices to cut, shave, or pulverize plaque have been tested extensively in coronary arteries. Some of these have also been approved for peripheral use. The future of angioplasty, beyond the tremendous success of conventional balloon catheters, depends on approaches that can reduce restenosis rates. For example, if appHcation of a dmg to the lesion site turns out to be the solution to restenosis, balloon catheters would be used for both dilating the vessel and deUvering the dmg. An understanding of what happens to the arterial walls, at the cellular level, when these walls are subjected to the various types of angioplasty may need to come first. [Pg.182]

Ha2ards were discovered by experience. It was soon found that x-rays produced skin bums and lesions that healed only slowly later it was learned that tumors could be produced. Within the medical community, it became clear that guidelines were needed for the use of x-rays, especially for medical workers, who were often present while the x-rays were produced. [Pg.442]

The biodistribution of the ideal radiopharmaceutical would show extremely rapid distribution via the circulatory system to the organs of interest and htfle distribution to others. It would be rapidly extracted by the organ or tissue of interest differentially in a way that reflects the disease process of interest. Ideally, abnormahties should be defined by substantial increases in the concentration of the agent because lesions defined by a decrease from surrounding concentrations, ie, cold-spot imaging, are more difficult to image. [Pg.473]

Kinetics of the biodistribution must be compatible with the practical aspects of hospital routine and imaging capabiUty. In the case of a diagnostic agent, maximal lesion contrast, maximal radioactivity concentrations in tissue of interest, and minimal background radioactivity during the time imaging... [Pg.473]

Instrumentation. The future of radiopharmaceuticals is highly dependent on imaging instmmentation. Instmmental methods can evolve rapidly. Performance and characteristics of these instmments are important in the choice of disease target, lesion size, location, and contrast. [Pg.485]


See other pages where Lesions is mentioned: [Pg.162]    [Pg.251]    [Pg.294]    [Pg.352]    [Pg.151]    [Pg.157]    [Pg.476]    [Pg.199]    [Pg.142]    [Pg.275]    [Pg.294]    [Pg.300]    [Pg.367]    [Pg.51]    [Pg.52]    [Pg.56]    [Pg.92]    [Pg.95]    [Pg.96]    [Pg.96]    [Pg.100]    [Pg.297]    [Pg.539]    [Pg.450]    [Pg.132]    [Pg.148]    [Pg.394]    [Pg.251]    [Pg.430]    [Pg.473]    [Pg.477]    [Pg.485]    [Pg.485]    [Pg.487]    [Pg.487]    [Pg.488]    [Pg.488]    [Pg.497]    [Pg.465]   
See also in sourсe #XX -- [ Pg.189 ]

See also in sourсe #XX -- [ Pg.22 , Pg.441 ]

See also in sourсe #XX -- [ Pg.85 , Pg.148 , Pg.226 , Pg.228 ]

See also in sourсe #XX -- [ Pg.37 ]




SEARCH



6-hydroxydopamine lesions

Abfraction lesions

Acidophilic cell lesion

Acute demyelinative lesions

Adenine lesion

Amygdala lesions

Analysis of Premalignant Lesions Using the TSCE Model

And brain lesions

And lesions

Anterior Cystic Lesion

Antidotes lesions

Arterial lesion

Atherosclerosis lesion development

Atherosclerosis lesions

Atherosclerotic lesions

Atherosclerotic lesions carotid

Atherosclerotic lesions muscle cells

Atherosclerotic lesions pathogenesis

Atherosclerotic lesions targeted

Balloon lesions

Basophilic lesions

Benign Liver Lesions

Bilateral lesion

Bile duct lesions

Biochemical Lesion

Bladder lesion

Bone lesions, distribution

Brain lesion studies

Brain lesion/lesioning

Brain lesions

Brain stem lesion

Breast lesions

Bypass lesion

Cancer precancerous lesions

Carcinogenesis lesion development

Cardiovascular lesions

Caries lesions

Caries, lesion formation

Cell membrane lesion

Cellular Membrane lesions

Cervical squamous intraepithelial lesions

Chemical lesion

Chemical lesion technique

Chemical lesions acidic substance

Chemical lesions chelators

Chemical lesions classification

Chemical lesions development

Chemical lesions lipids

Chemical lesions skin layers

Children skin lesions

Chronic total occlusion lesions

Clear cell lesion

Clustered lesions

Coronary lesions

Cortical lesions

Cyclobutane cytosine dimer lesions

DNA lesion recognition

DNA lesions

Damage Verification and Lesion Demarcation in NER

Degenerative lesions

Demineralization White spot lesions

Dendritic lesion

Dental lesion

Deoxyribonucleic acid lesions

Depressed lesion

Determination of DNA Lesions by Liquid Chromatography

Diabetes mellitus vascular lesion

Diagnosis lesions

Diffusion lesion

Diffusion lesion reversal

Direct toxic action, tissue lesions

Double-stranded lesions

Duodenal lesions

Dysplastic lesions

Electrolytic lesions

Elucidating Structure-Function Relationships in Bulky DNA Lesions From Solution Structures to Polymerases

Epithelial lesions

Erythematous lesions

Evolution of the Lesion

Excitotoxic lesions

Eye Lesions

Fibrotic lesions

Fibrous lesions

Focal lesions

Focal liver lesion

Gastric cancer precancerous lesions

Gastric lesions

Gastrointestinal ulcerative lesions

Genetic lesions, nature

Globus pallidus lesions

Glomerular lesions

Heart lesions

Heparins skin lesions

Hepatic lesions

Hepatic lesions carcinogenesis

Hepatic lesions carcinomas

Hepatic lesions microsomes

Hepatic lesions neoplasia

Hepatic lesions tumors

Herpes simplex lesions

High-grade squamous intraepithelial lesion

Hill-Sachs Lesion

Histology and Physiology of MS Lesions

Histopathologic lesion incidence

Histopathological lesions

Honey in the Treatment of Herpes Simplex Lesions

Hyperplastic lesion

Hypothalamic lesions

I lesioning

Ibotenic acid lesions

Immunotoxic lesions

Induced hypersensitive lesion

Inflamed lesion

Inflammatory CNS lesions

Intracranial lesioning

Intracranial structural lesions

Intraocular lesions

Intraventricular lesions

Janeway lesions

Kidney lesion

Lesion Diminutive

Lesion Location

Lesion Morphology

Lesion Mural

Lesion Pedunculated

Lesion Recognition by DNA Glycosylases

Lesion Sessile

Lesion Surveillance

Lesion bypass during

Lesion bypass oligonucleotide

Lesion development

Lesion diameters

Lesion embolic

Lesion expansion

Lesion medullary

Lesion mesencephalic

Lesion multiple

Lesion oxidative

Lesion recognition

Lesion site

Lesion size

Lesion subcortical

Lesion temporal

Lesion thalamic

Lesion unrepaired

Lesion, lung

Lesions Generated by Oxidative Damage to DNA

Lesions alkylated bases

Lesions associated with

Lesions containing

Lesions containing site-specific

Lesions excision

Lesions in DNA

Lesions mutagenesis induced

Lesions nucleobase

Lesions permanent

Lesions transient

Lesions, mucosal

Lesions, premalignant

Lichenified lesions

Liver benign solid lesion

Liver bile duct lesions

Liver lesions

Locus coeruleus lesions

Low-grade squamous intraepithelial lesion

Lower-motor neuron lesion

Lungs sulfur mustard-induced lesions

Lupus pernio lesions

Macrophages lesions starting with

Magnetic resonance imaging nervous system lesions

Mastocytosis skin lesions

Membrane lesions

Meniscal lesions

Meniscus Lesions

Metastatic liver lesion

Morphological lesions

Mucosal lesion, malignant

Multiple sclerosis lesions appearance

Mutations lesion detection

N2- -dG lesion

Nature of the Lesion

Neonatal lesions

Neoplastic Lesions in Man and Animal Models

Neoplastic lesions

Neovascular lesion

Nervous system lesions

Nervous system lesions biopsies

Nervous system lesions macrophages

Neural lesions

Neurofibrillary lesions

Neuropathological lesions

Neurotransmitter brain lesions

Nigrostriatal lesions

Nigrostriatal lesions MPTP)

Nigrostriatal system, lesions

Nipple Evolution of Lesions

Nucleotide excision repair lesion removal with

Nucleus accumbens lesions

OHDA lesion syndrome

Ocular lesions

Ocular toxicity lesions

Osteochondral lesions

Osteolytic lesion

Osteolytic metastatic lesions

Other Lesions

Oxidative DNA Lesions from PAH o-Quinones

Pancreas cystic lesion

Papillary lesions, breast

Paraquat-Induced Lesions of Tubular Brush Border in Man

Partial lesions

Patchy lesions

Pathological lesions

Pelvic lesion

Periventricular lesion

Pituitary lesions

Polycyclic Aromatic Hydrocarbons Multiple Metabolic Pathways and the DNA Lesions Formed

Potentially Cytotoxic Lesions

Potentially Mutagenic Lesions

Precancerous lesions

Premutagenic lesions

Preneoplastic lesion

Primary fat epiploic lesion

Proliferative ductal epithelial lesions

Pruritic lesions

Psoriasiform lesions

Psoriatic lesions

Psoriatic skin lesions

Pulmonary lesions

Radical-Mediated Pulmonary Lesions

Radiofrequency lesions

Recognition and Removal of Bulky DNA Lesions by the Nucleotide Excision Repair System

Recognition of Bulky Lesions by Mammalian NER Factors

Relationships between the Chemical, Structural, and Biological Features of DNA Lesions

Renal lesion

Renal parenchymal lesions

Renal tubular lesions

Repair of DNA Lesions

Repair of lesions

Sarcoid lesions

Sarcoidosis skin lesions

Scleroderma-like lesions

Scratch lesions

Selective Lesions

Single-Ventricle Lesions

Skin lesion

Skin lesions assessment

Skin lesions borders

Skin lesions patient history

Skin lesions types

Skin lesions, from biological agents

Skip lesion

Soft tissue lesion

Solitary lesion

Space occupying lesion

Spinal vascular lesion

Squamous intraepithelial lesion

Stener Lesion

Striatal kainic acid lesion

Striatal lesions

Substantia nigra lesions

Subthalamic lesions

Subthalamic nucleus lesions

Sugar lesions

Sulfur mustard forestomach lesions

Sulfur mustards lung lesions

Sulfur mustards skin lesions

Synchronous lesion

TILLING (targeted induced local lesions

Tandem base lesion

Tandem lesions

Target lesions

Targeting induced local lesions in genomes

Targeting induced local lesions in genomes TILLING)

Terminal lesions

Testicular lesions

Testing the model by mixed tasks in patients with monohemispheric brain lesion

The Vascular Lesion in Diabetes

The fatty streak and transition to more advanced lesion

The pathways of patients with monohemispheric brain lesions

The reaction times of patients with monohemispheric brain lesions

Thymine lesions, ring-saturated

Thyroid lesions

Tissue lesions

Tissue lesions kidney damage

Tissue lesions liver necrosis

Tissue lesions lung damage

Tooth enamel lesions

Toxicity lesions

Tubular lesions

Tumor lesions

Types of Chemically Induced Lesions

Types of DNA Lesions

Ulcerated lesions

Ultraviolet light lesions induced

Unilateral lesions

Upper motor neuron lesion

Vascular lesions, liver

Vessels Intima Lesions

Vicinal lesion

Vulvar lesions

Wedge-shaped renal lesions

White matter lesions

White phosphorus lesion

White spot lesion

© 2024 chempedia.info